Drug Shortage Report for AURO-LACOSAMIDE

Last updated on 2021-02-18 History
Report ID 132002
Drug Identification Number 02475340
Brand name AURO-LACOSAMIDE
Common or Proper name Lacosamide
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) LACOSAMIDE
Strength(s) 100MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 60's
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-01-18
Estimated end date
Actual end date 2021-02-11
Shortage status Resolved
Updated date 2021-02-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Balaji Srinivasan

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2021-02-18 French Compare
v6 2021-02-18 English Compare
v5 2021-01-29 French Compare
v4 2021-01-29 English Compare
v3 2021-01-29 English Compare
v2 2021-01-19 French Compare
v1 2021-01-19 English Compare

Showing 1 to 7 of 7